Systemic sclerosis
Conditions
Interventions
None listed
Sponsors
Yokohama City University Graduate School of Medicine, Department of Stem Cell and Immune Regulation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The published study including case-control study, cohort study, and randomized clinical trial. (2) The experimental group of the study was treated by HSCT, with or without control treatment arm. (3) The patients were clinically diagnosed with SSc. (5) The study illustrates the safety of HSCT. (6) Only full-text papers are used to analyze.
Exclusion criteria
Exclusion criteria: (1) Systematic review or meta-analysis articles. (2) Case reports or case series reporting less than 5 cases. (3) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (4) Studies with no or insufficient safety results at the time of the literature search. (5) Studies published in languages other than English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment related death | — |
Countries
Japan
Contacts
Public ContactKaoru Minegishi
Yokohama City University Graduate School of Medicine Department of Stem Cell and Immune Regulation
Outcome results
None listed